ClinicalTrials.gg
CompletedNCT05988983Updated Nov 19, 2026

The Over The Counter Pill National Study

An observational study in Contraception, Contraception Behavior and Contraceptive Usage, sponsored by Oregon Health and Science University. Completed at 1 site in United States. Open to female participants aged 15 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Oregon Health and Science University · Observational

How we know

Updated Nov 19, 2026Now CompletedEligibility revisedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,026
Ages
15 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 70 studies in Contraception Behavior with a site in United States — 10 open to participants now, 17 under way, none of them phase 3. Contraception Behavior · United States.

Started
2024
with 3 others
Observational
9 of 70
none open now
Registered
63rd of 70
by date
Lead sponsor
5 of 70
Oregon Health and Science University

Among the 70 studies in Contraception Behavior with a site in United States, this one is one of 4 that started in 2024, is one of 9 observational ones, and was the 63rd registered.

Contraception Behavior

132 studies on the registry are indexed under Contraception Behavior; 20 are open to participants now.

Browse Contraception Behavior studies →

Open to participants now

10 of the 70 studies in Contraception Behavior with a site in United States are open now. Recruiting first, the newest first:

5 more — sign in →

All 10 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 13 Contraception Behavior studies recruiting now, 3 (23%) set no upper age limit and 10 (77%) stop at 75 or younger; 4 take children under 18; 10 take healthy volunteers.

This study: 15 Years to 45 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 70 studies in Contraception Behavior with a site in United States, or all of them as a file.
02

Study summary

This is a prospective cohort study of individuals purchasing the oral contraceptive pill over the counter (OTC) in pharmacies across all 50 states in the country. The comparison group is people receiving a prescription (Rx) for oral contraception. Both groups will be followed for one year to examine contraceptive continuation rates. This study will also identify who is using the pill OTC and why and evaluate differences in pregnancy intention and measures of contraceptive agency between the two groups.

03

Conditions studied

  • Contraception
  • Contraception Behavior
  • Contraceptive Usage
  • Health Care Utilization
04

Who can participate

Ages eligible
15 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Individuals aged 12 to 51 who are obtaining the oral contraceptive pill at a pharmacy for the purposes of pregnancy prevention.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Capable of pregnancy
  • Purchasing oral at a participating pharmacy

Exclusion criteria

Exclusion Criteria:

  • Using the pill for non indications
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,026 participants (actual)
Patient registry
No

Groups and cohorts

  • OTC users

    Participants using the oral contraceptive pill purchased over the counter

    Other: Availability of OTC contraceptive pill

  • Rx users

    Participants using the oral contraceptive pill received by a prescription

Interventions

  • OtherAvailability of OTC contraceptive pill

    Over the counter contraceptive pill

06

What researchers measure

Primary outcomes

  1. 12 month contraceptive continuation rates

    Difference in proportion of participants using contraception 12 months after starting between over the counter and prescription groups.

    Time frame: 12 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2024 to primary completion in Mar 2026, 22 months.

Of 11 observational studies under Contraception Behavior, half reached primary completion within 17 months of starting (the median); a quarter within 14 and three quarters within 22. This study's 22 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 3, 2023
First posted
Aug 14, 2023
StartActual
May 1, 2024
Primary completionActual
Mar 3, 2026
CompletionActual
Mar 3, 2026
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Nov 19, 2026
Eligibility
Minimum age 12 Years→15 Years; Maximum age 51 Years→45 Years
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Active, not recruiting→Completed
    Eligibility Minimum age 12 Years→15 Years; Maximum age 51 Years→45 Years
    + 6 other changes: identifiers, verification date, date precision, responsible party, oversight details and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05988983
Collaborators
Arnold Ventures
Responsible party
Maria Rodriguez, MD, MPH (Professor of Obstetrics and Gynecology, Oregon Health and Science University) — Principal investigator
First posted
Aug 14, 2023
Start date
May 1, 2024
Primary completion
Mar 3, 2026
Completion
Mar 3, 2026
Last update
Nov 19, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion